Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -149,150
▼ 145% vs 2024
Profit
Caution€ -620,962
▼ 549% vs 2024
Debts
Normal€ 4.8 million
▲ 30% vs 2024
APIX Biosciences from Wingene, company number BE0771667563, closed financial year 2025 with a result of € -620,962 after tax. For that financial year APIX Biosciences recorded a gross margin of € -149,150 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € -95,737 to € -620,962. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on November 28, 2025.
What happened at APIX Biosciences?
What happened at APIX Biosciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- DE LIER BV stepped down as director. NBB
- MAARTEN DUYCK stepped down as director. NBB
- MYRMEX BV stepped down as director. NBB
- THIERRY BOGAERT stepped down as director. NBB
- SHARON SHAFIR stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 620,962. Source: NBB ↗
- DE LIER BV became a director. NBB
- MAARTEN DUYCK became a director. NBB
In short
From € 23,770 loss in 2022 to € 620,962 loss in 2025.
On average € 87,400 of value added per employee in 2024.
A new publication or filing at APIX Biosciences? We notify you, reason included.
Follow APIX BiosciencesNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of APIX Biosciences Holdings Inc. and 100% of APIX Nutrition Ltd. itself.
Directors
According to the 2025 annual accounts
Director · represented by FRANCOIS VAN LIERDE
Also active at: ACKERMANS & VAN HAAREN, Protealis
since 2025 · until 2031
since 2021 · until 2027
since 2021 · until 2027
since 2025 · until 2031
SHARON SHAFIR
Director
since 2021 · until 2027
Establishments
Establishment units
Physical locations of this company
Blauwhuisstraat 11
8750 Wingene
Blauwhuisstraat 4
8750 Wingene
Active since 22 August 2021
Beernemsteenweg 77B
8750 Wingene
Active since 23 July 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
ALASAN
PARANG
Mellona
MYRMEX same network
€ 49,468 gross margin · 2025
Phytant same network
€ -2,064 gross margin · 2025
+2 more
Details
- Company number
- 0771.667.563
- VAT number
- BE 0771.667.563
- Registered office
- Blauwhuisstraat 11, 8750 Wingene
- Names & denominations
- APIX Biosciences
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 July 2021
- Peppol
- Active · Active since 11 Aug 2026
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Diverse administratieve activiteiten ten behoeve van kantoren
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied